These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6100122)

  • 41. A comparison of the antibiotic activities of sisomicin, gentamicin and aminosidine sulphate against pseudomonas aeruginosa.
    Pitzus E; Ghinelli P; Turano A; Romano F; Cadenelli GP
    J Int Med Res; 1978; 6(5):418-9. PubMed ID: 100354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic synergy: clinical applications and an in vitro study of cefotaxime-aminoglycoside combinations.
    Faris HM; Dreskin RB
    J S C Med Assoc; 1983 May; 79(5):275-7. PubMed ID: 6308348
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
    Elliott AM; Karam GH; Cobbs CG
    Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
    Brummett RE; Fox KE; Bendrick TW; Himes DL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():73-83. PubMed ID: 659353
    [No Abstract]   [Full Text] [Related]  

  • 45. A broth-disc technique for the assay of antibiotic synergism.
    Meyer M; Hofherr L
    Can J Microbiol; 1979 Nov; 25(11):1232-8. PubMed ID: 120215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.
    Gangadharam PR; Candler ER
    Tubercle; 1977 Mar; 58(1):35-8. PubMed ID: 405778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The in vitro activity of sisomicin and gentamicin against Ps. aeruginosa (author's transl)].
    Zaror L; Ferńandez H; Otth L; Gutiérrez A; Tejero A; Wilson G
    Rev Med Chil; 1979 Mar; 107(3):261-3. PubMed ID: 112658
    [No Abstract]   [Full Text] [Related]  

  • 48. Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics.
    Klastersky J; Beumer J; Daneau D
    Pathol Biol (Paris); 1972 Sep; 20(15):643-7. PubMed ID: 4342650
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin.
    Calderwood SB; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):549-55. PubMed ID: 6264851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
    Sanders WE; Sanders CC
    J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
    [No Abstract]   [Full Text] [Related]  

  • 52. [Carbenicillin and gentamycin. In vitro investigations of 2 broad-spectrum antibiotics active against Pseudomonas aeruginosa].
    Rosdahl N; Thomsen VF
    Ugeskr Laeger; 1971 Sep; 133(37):1817-22. PubMed ID: 5001170
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of the activity of netilmicin and gentamicin in vitro on bacteria isolated from the oro-pharynx].
    Pase U; Pascotto P; Bagolan A
    G Stomatol Ortognatodonzia; 1984; 3(3):355-7. PubMed ID: 6443212
    [No Abstract]   [Full Text] [Related]  

  • 55. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L; Orsolini P; Broggio R
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
    Vincent P; Vachée A; Izard D
    Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of combined use of antibiotics against Pseudomonas aeruginosa in vitro.
    Kobayashi Y
    Keio J Med; 1976 Dec; 25(4):151-62. PubMed ID: 829361
    [No Abstract]   [Full Text] [Related]  

  • 59. [In vitro activity of gentamicin against 5 bacteria species].
    Bersani S; Pompei L
    G Ital Chemioter; 1969; 16(1):16-26. PubMed ID: 4998301
    [No Abstract]   [Full Text] [Related]  

  • 60. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.